晚期胃癌-话题@MedSci

#晚期胃癌#

96篇内容 | 5732人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1276629, encodeId=d91a12e6629d9, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer: 纳武利尤单抗（nivolumab）治疗既往治疗进展的晚期胃癌的疗效：ATTRACTION-2研究结果更新, objectType=article, longId=213460, objectId=af9621346022, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af9621346022, replyNumber=0, likeNumber=98, createdTime=2021-06-30, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af9621346022, moduleTitle=Gastric Cancer: 纳武利尤单抗（nivolumab）治疗既往治疗进展的晚期胃癌的疗效：ATTRACTION-2研究结果更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af9621346022)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276628, encodeId=4c5312e6628bf, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后, objectType=article, longId=212904, objectId=f025212904a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f025212904a5, replyNumber=0, likeNumber=108, createdTime=2021-06-20, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f025212904a5, moduleTitle=J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f025212904a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276627, encodeId=3c0012e66274d, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：雷莫芦单抗（ramucirumab）治疗晚期胃癌的疗效和安全性：来自日本的上市后观察性真实世界研究, objectType=article, longId=212152, objectId=b749212152b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b749212152b2, replyNumber=0, likeNumber=113, createdTime=2021-06-03, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b749212152b2, moduleTitle=Gastric Cancer：雷莫芦单抗（ramucirumab）治疗晚期胃癌的疗效和安全性：来自日本的上市后观察性真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b749212152b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276626, encodeId=f19212e662691, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=O药新惊喜：美FDA首次批准用于晚期胃癌一线治疗的免疫疗法, objectType=article, longId=210099, objectId=8c11210099b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c11210099b0, replyNumber=0, likeNumber=64, createdTime=2021-04-19, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c11210099b0, moduleTitle=O药新惊喜：美FDA首次批准用于晚期胃癌一线治疗的免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c11210099b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276625, encodeId=964112e6625c3, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Lancet Gastroenterol Hepatol：Lonsurf联合雷莫芦单抗治疗不可切除的晚期胃癌疗效和安全性, objectType=article, longId=206331, objectId=9adb20633151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9adb20633151, replyNumber=0, likeNumber=84, createdTime=2021-01-29, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9adb20633151, moduleTitle=Lancet Gastroenterol Hepatol：Lonsurf联合雷莫芦单抗治疗不可切除的晚期胃癌疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9adb20633151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276624, encodeId=17ce12e6624b8, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Clin Cancer Res：纳武单抗+紫杉醇+雷莫芦单抗治疗晚期胃癌的疗效未来可期！, objectType=article, longId=205187, objectId=74bc20518eef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74bc20518eef, replyNumber=0, likeNumber=119, createdTime=2021-01-03, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74bc20518eef, moduleTitle=Clin Cancer Res：纳武单抗+紫杉醇+雷莫芦单抗治疗晚期胃癌的疗效未来可期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74bc20518eef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276623, encodeId=f17812e66236c, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Nat Commun：Ⅱ期随机临床试验: 局部晚期胃癌患者新辅助FLOT与SOX疗法较量, objectType=article, longId=203999, objectId=4c6120399925, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c6120399925, replyNumber=0, likeNumber=90, createdTime=2020-12-03, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c6120399925, moduleTitle=Nat Commun：Ⅱ期随机临床试验: 局部晚期胃癌患者新辅助FLOT与SOX疗法较量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c6120399925)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276622, encodeId=e81612e66221b, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=J Clin Oncol：III期 | 一线诱导化疗后Avelumab维持治疗对晚期胃癌患者预后的作用, objectType=article, longId=203571, objectId=92742035e184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92742035e184, replyNumber=0, likeNumber=109, createdTime=2020-11-22, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92742035e184, moduleTitle=J Clin Oncol：III期 | 一线诱导化疗后Avelumab维持治疗对晚期胃癌患者预后的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92742035e184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276621, encodeId=036912e6621c6, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Derazantinib治疗晚期胃癌：即将开展I/II期研究, objectType=article, longId=201355, objectId=2779201355ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2779201355ed, replyNumber=0, likeNumber=106, createdTime=2020-09-30, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2779201355ed, moduleTitle=Derazantinib治疗晚期胃癌：即将开展I/II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2779201355ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276620, encodeId=6f9012e6620ed, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：波齐替尼联合紫杉醇和曲妥珠单抗治疗HER2阳性晚期胃癌患者的效果, objectType=article, longId=198092, objectId=8f48198092eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f48198092eb, replyNumber=0, likeNumber=89, createdTime=2020-07-28, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f48198092eb, moduleTitle=Gastric Cancer：波齐替尼联合紫杉醇和曲妥珠单抗治疗HER2阳性晚期胃癌患者的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f48198092eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276619, encodeId=faf012e6619d0, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Lancet Oncol：乐伐替尼联合派姆单抗治疗晚期胃癌, objectType=article, longId=196434, objectId=1726196434bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1726196434bb, replyNumber=0, likeNumber=77, createdTime=2020-06-26, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1726196434bb, moduleTitle=Lancet Oncol：乐伐替尼联合派姆单抗治疗晚期胃癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1726196434bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276618, encodeId=9de312e661826, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Lancet oncol：仑伐替尼和派姆单抗联合治疗晚期胃癌, objectType=article, longId=196409, objectId=534919640909, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=534919640909, replyNumber=0, likeNumber=96, createdTime=2020-06-26, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=534919640909, moduleTitle=Lancet oncol：仑伐替尼和派姆单抗联合治疗晚期胃癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=534919640909)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276617, encodeId=ea2d12e661749, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=NEJM: Trastuzumab Deruxtecan治疗HER2阳性晚期胃癌II期效果显著, objectType=article, longId=196097, objectId=c0f719609e16, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0f719609e16, replyNumber=0, likeNumber=102, createdTime=2020-06-20, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0f719609e16, moduleTitle=NEJM: Trastuzumab Deruxtecan治疗HER2阳性晚期胃癌II期效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0f719609e16)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276616, encodeId=f20912e661642, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标 , objectType=article, longId=193856, objectId=ff2119385640, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff2119385640, replyNumber=0, likeNumber=133, createdTime=2020-05-11, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff2119385640, moduleTitle=Gastric Cancer：L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff2119385640)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276615, encodeId=cafd12e6615b9, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=免疫治疗时代下的晚期胃癌治疗, objectType=article, longId=192419, objectId=c40019241934, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c40019241934, replyNumber=0, likeNumber=117, createdTime=2020-04-19, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c40019241934, moduleTitle=免疫治疗时代下的晚期胃癌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c40019241934)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276614, encodeId=f3f212e66143e, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=JAMA Surg：新辅助化疗后腹腔镜远端局部晚期胃癌的疗效, objectType=article, longId=185410, objectId=e22b185410d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e22b185410d3, replyNumber=0, likeNumber=71, createdTime=2019-12-31, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e22b185410d3, moduleTitle=JAMA Surg：新辅助化疗后腹腔镜远端局部晚期胃癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e22b185410d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276613, encodeId=5fc912e66131c, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer： L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标, objectType=article, longId=184837, objectId=6ba418483e52, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ba418483e52, replyNumber=0, likeNumber=79, createdTime=2019-12-18, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ba418483e52, moduleTitle=Gastric Cancer： L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ba418483e52)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276612, encodeId=3aa612e66120b, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=Gastric Cancer：不可切除的晚期胃癌患者血清碱性磷酸酶和乳酸脱氢酶水平的预后意义, objectType=article, longId=181684, objectId=d3a6181684c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a6181684c4, replyNumber=0, likeNumber=76, createdTime=2019-10-23, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a6181684c4, moduleTitle=Gastric Cancer：不可切除的晚期胃癌患者血清碱性磷酸酶和乳酸脱氢酶水平的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a6181684c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276611, encodeId=029912e66110c, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=局部晚期胃癌优化治疗模式的探寻, objectType=article, longId=181034, objectId=0902181034b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0902181034b7, replyNumber=0, likeNumber=89, createdTime=2019-10-14, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0902181034b7, moduleTitle=局部晚期胃癌优化治疗模式的探寻, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0902181034b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1276610, encodeId=764c12e6610fe, content=<a href='/topic/show?id=59ed598e816' target=_blank style='color:#2F92EE;'>#晚期胃癌#</a>, objectTitle=【2019 ESMO】林榕波教授团队报道四药联合方案治疗晚期胃癌, objectType=article, longId=180680, objectId=779218068058, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=779218068058, replyNumber=0, likeNumber=112, createdTime=2019-10-10, rootId=0, userName=drj2003, userId=80c5136, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=779218068058, moduleTitle=【2019 ESMO】林榕波教授团队报道四药联合方案治疗晚期胃癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=779218068058)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

晚期胃癌

2020-05-29

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer: 纳武利尤单抗（nivolumab）治疗既往治疗进展的晚期胃癌的疗效：ATTRACTION-2研究结果更新

2021-06-30

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

J Clin Oncol：新辅助DOS化疗可在标准疗法基础上进一步改善可切除局部晚期胃癌患者预后

2021-06-20

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：雷莫芦单抗（ramucirumab）治疗晚期胃癌的疗效和安全性：来自日本的上市后观察性真实世界研究

2021-06-03

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

O药新惊喜：美FDA首次批准用于晚期胃癌一线治疗的免疫疗法

2021-04-19

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Lancet Gastroenterol Hepatol：Lonsurf联合雷莫芦单抗治疗不可切除的晚期胃癌疗效和安全性

2021-01-29

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Clin Cancer Res：纳武单抗+紫杉醇+雷莫芦单抗治疗晚期胃癌的疗效未来可期！

2021-01-03

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Nat Commun：Ⅱ期随机临床试验: 局部晚期胃癌患者新辅助FLOT与SOX疗法较量

2020-12-03

爆笑小医 (审核中...)

前往app查看评论内容

#晚期胃癌#

J Clin Oncol：III期 | 一线诱导化疗后Avelumab维持治疗对晚期胃癌患者预后的作用

2020-11-22

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Derazantinib治疗晚期胃癌：即将开展I/II期研究

2020-09-30

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：波齐替尼联合紫杉醇和曲妥珠单抗治疗HER2阳性晚期胃癌患者的效果

2020-07-28

docwu2019 (审核中...)

前往app查看评论内容

#晚期胃癌#

Lancet Oncol：乐伐替尼联合派姆单抗治疗晚期胃癌

2020-06-26

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Lancet oncol：仑伐替尼和派姆单抗联合治疗晚期胃癌

2020-06-26

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

NEJM: Trastuzumab Deruxtecan治疗HER2阳性晚期胃癌II期效果显著

2020-06-20

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标

2020-05-11

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

免疫治疗时代下的晚期胃癌治疗

2020-04-19

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

JAMA Surg：新辅助化疗后腹腔镜远端局部晚期胃癌的疗效

2019-12-31

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer： L1甲基化与肿瘤浸润淋巴细胞的组合可作为晚期胃癌的预后指标

2019-12-18

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

Gastric Cancer：不可切除的晚期胃癌患者血清碱性磷酸酶和乳酸脱氢酶水平的预后意义

2019-10-23

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

局部晚期胃癌优化治疗模式的探寻

2019-10-14

drj2003 (审核中...)

前往app查看评论内容

#晚期胃癌#

【2019 ESMO】林榕波教授团队报道四药联合方案治疗晚期胃癌

2019-10-10

科室
- - 订阅+
  - 更多科室
工具
服务